Northwind Pharmaceuticals LLC 2023-05-03 Health serious FDA
Health · FDA · Recall #FDA-D-0551-2023
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and… Recall
Issued May 3, 2023 · Northwind Pharmaceuticals LLC
In May 2023, Northwind Pharmaceuticals LLC recalled the Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations
What you should do
- 1 Stop using Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Northwind Pharmaceuticals LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Northwind Pharmaceuticals LLC
- Category
- Health
- Recall date
- May 3, 2023
- Units affected
- Not reported
- Sold at
- Nationwide with the United States
- Recall number
- FDA-D-0551-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Northwind Pharmaceuticals LLC has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.